A Post Marketing Surveillance (PMS) Study to Monitor the Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Female Chinese Subjects

NCT03438006 · clinicaltrials.gov ↗

COMPLETED

Status

3016

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Intraepithelial Neoplasia

Interventions

OTHER: Safety data collection (following routine vaccination)

Sponsor

GlaxoSmithKline